| 000 | 01449 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512031538.0 | ||
| 264 | 0 | _c19860801 | |
| 008 | 198608s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.83.13.4918 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEvans, B E | |
| 245 | 0 | 0 |
_aDesign of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJul 1986 |
||
| 300 |
_a4918-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepines _xchemical synthesis |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Cholecystokinin |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBock, M G | |
| 700 | 1 | _aRittle, K E | |
| 700 | 1 | _aDiPardo, R M | |
| 700 | 1 | _aWhitter, W L | |
| 700 | 1 | _aVeber, D F | |
| 700 | 1 | _aAnderson, P S | |
| 700 | 1 | _aFreidinger, R M | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 83 _gno. 13 _gp. 4918-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.83.13.4918 _zAvailable from publisher's website |
| 999 |
_c3020336 _d3020336 |
||